While these peptides demonstrate promising therapeutic potential based on preclinical research, clinical evidence remains limited, and their use should be approached as experimental therapy requiring careful risk-benefit analysis
Inflammatory Bowel Disease (IBD) and Crohns disease: BPC-157 has been found to reduce inflammation, restore gut mucosa, and prevent damage in experimental colitis models, making it a potential therapeutic agent for Crohns disease and ulcerative colitis (Seiwerth et al., 2014)
Lipotropic injections, also frequently called Lipo-C injections, supposedly give the body a boost of these fat-burning lipotropes, the result of which is an increase in fat-burning and a decrease in weight
Both metformin and long-term use of proton pump inhibitors have been linked to reduced B12, and the same goes for many people past 50